This site uses cookies. By using this site you agree to receiving cookies. View Policy.

157%

PCL Health's tech-driven approach aims to bring hospital-level care to anyone remotely. With CE Marked medical grade devices designed to pair with a health algorithm and our proprietary Apps, they aim to supercharge users to monitor the health of their beloved. Join their mission to create technology that saves time, money and lives.

  • Certified UCL supplier for Contact Tracing Trial in Senegal, Africa
  • Initial interest received from NHS Trusts and CCGs
  • Named Supplier to Crown Commercial Service (CCS) Framework
  • Received LOI for clinical trial by NH Homerton University Hospital
Information £245,000 of the funds on the progress bar have already been invested, funds received and shares issued prior to going live. The completion of the Crowdcube proportion of the raise will be at the same share price and share class.

Idea

The UK spends 10% of its GDP on healthcare and around 10% of that budget goes to the over 85's. Correct use of remote monitoring can reduce mortality by up to 45%. It is therefore no surprise that the market is growing at 38% a year and is set to reach $30 billion by 2023. Remote healthcare is only at the beginning of a very long growth trend.

PCL Health plans to operate a B2B SaaS model to solve a problem for doctors, hospitals and care homes. Our platform uses health algorithms combined with sensors and our proprietary Apps to allow family members to proactively monitor the health of their loved ones, alongside carers and doctors, remotely.

With the help of predictive algorithms, our clinical dashboard is designed to reveal real-time deterioration in a patient's health and can form an early warning score to alert users about upcoming health risks. It will save doctors time and could enable them to pick up health problems before they become severe.

Our Key Milestones achieved include:

- Built Online Connected-Care platform and Mobile Apps

- Completed 2 pilots with 65 people

- Received LOI from a NHS Trust for a clinical trial

- Named as a supplier on Crown Commercial Services

- Signed Contract with UCL for paid Contract-Tracing pilot

- Won Innovative Startup competition at Healthcare Unblocked 2019

Funds will be used for tech enhancement, running pilots and working capital.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the PCL Health pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered?
Log in

Risk warning

Investments of this nature carry risks to your capital, including illiquidity, lack of dividends and dilution. Balance risk with a diversified portfolio. Read more. Approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

PCL Health has been given advance assurance by HMRC that the proposed share issue is likely to qualify for Enterprise Investment Scheme (EIS) tax relief.

Tax relief is available to individuals only, with income tax relief currently set at 30 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More.

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.